Laboratoire Riva Inc Pharmaceutical Import Profile — Canada (DGFT 2022–2026)

Name: Laboratoire Riva Inc Pharmaceutical Import Records from India — 2 Products, $4.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Laboratoire Riva Inc — Pharmaceutical Importer Profile (2026) | 2 Products, $4.0M Trade | TransData Nexus

Laboratoire Riva Inc

Pharmaceutical Importer · Canada · Analgesics & Antipyretics Focus · $4.0M Total Trade · DGFT Verified

Laboratoire Riva Inc is a pharmaceutical importer based in Canada with a total trade value of $4.0M across 2 products in 2 therapeutic categories. Based on 80 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Laboratoire Riva Inc sources from 7 verified Indian suppliers, with Granules India Limited accounting for 37.2% of imports.

Laboratoire Riva Inc — Import Portfolio & Supplier Network

Laboratoire Riva Inc import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Laboratoire Riva Inc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Granules India Limited	$2.5M	52	37.2%
Alembic Pharmaceuticals Limited	$1.7M	52	24.7%
Intas Pharmaceuticals Limited

What Formulations Does Laboratoire Riva Inc Import?

Formulation	Value	Ships
Acetaminophen tablets USP 500MG	$350.0K	7
Compresso pap 90	$250.0K	5
Compresso pap 90 cpc(acetaminophen directly compressible granules)	$250.0K	5
Riva-pyridostigmine/pyridostigmine	$178.9K	6
Pharma drugs and medi riva-apixaban 5MG	$169.8K	4
Compresso pap 90	$150.0K	3
Acetaminophen tablets USP 500MG(easy	$150.0K	3
Acetaminophen tablets USP 500MG(easy toswallow)-90000-riva/canada (32,130.000 pac	$150.0K	3
Venlafaxine xr 150MG 500caps_riva	$150.0K	3
Acetaminophen tablets USP	$150.0K	3
Acetaminophen tablets USP 500MG(easy toswallow)-90000-riva /canada (32008.891)	$150.0K	3
Venlafaxine xr 75MG 500caps_riva	$149.0K	3
Venlafaxine xr 37.5MG 100 CAPS as per	$109.6K	3
Venlafaxine xr 150MG 500caps_riva cn	$100.0K	2
Venlafaxine xr 37.5MG 500caps_riva cn	$100.0K	2

Laboratoire Riva Inc imports 133 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Acetaminophen	Analgesics & Antipyretics	$2.0M	40	0.9%	5
2	Amino	Nutritional Supplements	$2.0M	40	0.6%	5

Laboratoire Riva Inc imports 2 pharmaceutical products across 2 categories into Canada totaling $4.0M.

Laboratoire Riva Inc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Laboratoire Riva Inc. is a Canadian pharmaceutical company specializing in the manufacturing of generic medications. Established over 45 years ago in Blainville, Quebec, the company has grown to employ a team of more than 100 professionals. Laboratoire Riva is recognized for its commitment to innovation, utilizing advanced manufacturing technologies to produce cost-effective pharmaceutical products. The company emphasizes strong relationships with Canadian retail pharmacists, ensuring that its offerings meet the evolving needs of the healthcare market.

In addition to its manufacturing operations, Laboratoire Riva Inc. engages in research and development to guarantee long-term satisfaction and loyalty among its partners. The company's dedication to quality and customer service has solidified its position as a leader in Canada's generic pharmaceutical sector.

2Distribution Network

Laboratoire Riva Inc. operates a centralized distribution network from its headquarters in Blainville, Quebec. The company maintains a robust logistics system to ensure timely delivery of its pharmaceutical products across Canada. While specific warehouse locations and logistics capabilities are not publicly detailed, Laboratoire Riva's established presence in the Canadian market indicates a well-organized distribution framework.

3Industry Role

Laboratoire Riva Inc. plays a pivotal role in Canada's pharmaceutical supply chain as a primary wholesaler and manufacturer of generic drugs. By producing cost-effective alternatives to brand-name medications, the company contributes to the accessibility and affordability of healthcare in Canada. Its strong relationships with retail pharmacists and commitment to quality underscore its significant position within the industry.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Laboratoire Riva Inc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Laboratoire Riva Inc. demonstrates a high level of supplier concentration in its sourcing strategy. The company's total import value from India amounts to $4.0 million USD, distributed across 80 shipments. The top five products imported are Acetaminophen and Amino, each valued at $2.0 million USD, accounting for 50% of the total import value. This indicates a strategic focus on these specific products, which may be driven by market demand and therapeutic needs.

The supplier base comprises seven unique Indian suppliers, with Granules India Limited being the largest contributor at $2.5 million USD (52 shipments, 37.2%). Alembic Pharmaceuticals Limited follows with $1.7 million USD (52 shipments, 24.7%), and Intas Pharmaceuticals Limited with $1.6 million USD (91 shipments, 24.0%). The remaining suppliers contribute smaller amounts, reflecting a diversified yet concentrated sourcing approach.

This concentration suggests that Laboratoire Riva Inc. has established strong, long-term relationships with its primary suppliers, which may offer benefits such as favorable pricing and consistent product quality. However, this dependency also poses risks related to supply chain disruptions or changes in supplier dynamics.

2Supply Chain Resilience

Laboratoire Riva Inc.'s supply chain resilience is influenced by its concentrated sourcing from a limited number of Indian suppliers. While the company has diversified its supplier base to include seven unique suppliers, the majority of its imports are concentrated among three primary suppliers: Granules India Limited, Alembic Pharmaceuticals Limited, and Intas Pharmaceuticals Limited.

Importing Pharmaceuticals into Canada — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Canada

1Regulatory Authority & Framework

In Canada, the regulation of pharmaceutical products is overseen by Health Canada, the federal department responsible for national public health. The primary legislation governing pharmaceutical imports is the Food and Drugs Act, along with its associated regulations, which set out the requirements for the importation, sale, and distribution of drugs in Canada. (canada.ca)

For a pharmaceutical product to be marketed in Canada, it must receive a Drug Identification Number (DIN) from Health Canada, indicating that the product has been assessed and authorized for sale. This process ensures that imported drugs meet the necessary safety, efficacy, and quality standards. (canada.ca)

2Import Licensing & GMP

Importers of pharmaceutical products in Canada must hold an Establishment Licence (EL) for the activity of import, as specified in section C.01A.008 of the Food and Drug Regulations. The foreign manufacturing site must be listed on the importer's EL, ensuring that the imported products are sourced from facilities recognized by Health Canada. (canada.ca)

Regarding Good Manufacturing Practice (GMP), Health Canada recognizes certifications from reputable international bodies, including the European Union (EU) GMP, World Health Organization (WHO) GMP, and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). These certifications attest to the manufacturing quality of pharmaceutical products and are essential for importation into Canada. (canada.ca)

Laboratoire Riva Inc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Laboratoire Riva Inc.'s focus on importing products in the Analgesics & Antipyretics and Nutritional Supplements categories reflects strategic alignment with prevalent health concerns and market demand in Canada. Acetaminophen, a widely used analgesic and antipyretic, and Amino, a nutritional supplement, are among the top imported products, each valued at $2.0 million USD. This emphasis indicates a targeted approach to address common health issues and consumer needs.

The company's investment in research and development supports the introduction of innovative products in these therapeutic areas, aiming to enhance patient outcomes and satisfaction. By focusing on these categories, Laboratoire Riva Inc. positions itself to meet the evolving demands of the Canadian healthcare market effectively.

2Sourcing Profile

Laboratoire Riva Inc. primarily sources generic drugs from India, leveraging the country's established pharmaceutical manufacturing capabilities. The company's import data indicates a concentration on specific products, such as Acetaminophen and Amino, sourced from key Indian suppliers like Granules India Limited, Alembic Pharmaceuticals Limited, and Intas Pharmaceuticals Limited. This sourcing strategy allows Laboratoire Riva Inc. to offer cost-effective alternatives to brand-name medications, aligning with its mission to provide affordable healthcare solutions.

India's adherence to international GMP standards and its competitive pricing make it a favorable sourcing destination for Laboratoire Riva Inc. The company's focus on finished pharmaceutical formulations ensures that imported products are ready for distribution, streamlining the supply chain and meeting market demands efficiently.

Seller's Guide — How to Become a Supplier to Laboratoire Riva Inc

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

For new Indian suppliers, there is a realistic opportunity to partner with Laboratoire Riva Inc. by meeting the company's quality standards and supply requirements. The existing supplier base is concentrated among a few key players, indicating potential gaps that new entrants can fill. By offering high-quality products, competitive pricing, and reliable

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Laboratoire Riva Inc

What products does Laboratoire Riva Inc import from India?

Laboratoire Riva Inc imports 2 pharmaceutical products across 2 categories. Top imports: Acetaminophen ($2.0M), Amino ($2.0M).

Who supplies pharmaceuticals to Laboratoire Riva Inc from India?

Laboratoire Riva Inc sources from 7 verified Indian suppliers. The primary supplier is Granules India Limited (37.2% of imports, $2.5M).

What is Laboratoire Riva Inc's total pharmaceutical import value?

Laboratoire Riva Inc's total pharmaceutical import value from India is $4.0M, based on 80 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Laboratoire Riva Inc focus on?

Laboratoire Riva Inc imports across 2 categories. The largest: Analgesics & Antipyretics (50.0%), Nutritional Supplements (50.0%).

Get Full Laboratoire Riva Inc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.